Abstract | BACKGROUND: METHODS: Using Taiwan's National Health Insurance Research Database, we retrospectively evaluated patients who underwent EVAR and TEVAR therapy between January 1, 2006, and December 31, 2013. RESULTS: A total of 146 patients with LC and 730 matched patients without LC were eligible for analysis after propensity score matching. In-hospital mortality and perioperative complications were not statistically significantly different between the two cohorts, although the LC group had an increased volume of blood transfusion and a trend toward a lower survival rate (P of stratified Cox = .092). However, patients with LC had a higher adjusted hazard ratio for death (1.66; 95% confidence interval, 1.31-2.12; P < .001) in the sensitivity analysis by traditional multivariable adjustment. The LC cohort had a higher risk of liver-related death (4.1% vs 0.7%; P = .001) and liver-related readmission (6.2% vs 0.3%; P < .001). As expected, the advanced LC group had a higher mortality rate than the early LC group (P = .022). The risk for reintervention, redo open aortic surgery (P = .859), and redo stent graft therapy (P = .179) was not statistically significantly different between the two cohorts. CONCLUSIONS: Short-term results after EVAR and TEVAR are promising in patients with LC, despite poor long-term outcomes, because of the nature of LC. Innovations in endovascular therapy for aortic disease have improved surgical outcomes, even in high-risk patients with LC.
|
Authors | An-Hsun Chou, Ching-Chang Chen, Yu-Sheng Lin, Ming-Shyan Lin, Victor Chien-Chia Wu, Pei-Chi Ting, Shao-Wei Chen |
Journal | Journal of vascular surgery
(J Vasc Surg)
Vol. 69
Issue 5
Pg. 1395-1404.e4
(05 2019)
ISSN: 1097-6809 [Electronic] United States |
PMID | 30528408
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved. |
Topics |
- Adult
- Aged
- Aged, 80 and over
- Aorta, Thoracic
(drug effects, surgery)
- Aortic Diseases
(diagnostic imaging, epidemiology, mortality, surgery)
- Blood Vessel Prosthesis
- Blood Vessel Prosthesis Implantation
(adverse effects, instrumentation, mortality)
- Databases, Factual
- Endovascular Procedures
(adverse effects, instrumentation, mortality)
- Female
- Hospital Mortality
- Humans
- Liver Cirrhosis
(diagnosis, epidemiology, mortality)
- Male
- Middle Aged
- Patient Readmission
- Postoperative Complications
(mortality, therapy)
- Retrospective Studies
- Risk Factors
- Stents
- Taiwan
(epidemiology)
- Time Factors
- Treatment Outcome
|